NEA Partners 15, L.P.'s Net Worth
$812 Million
Who is NEA Partners 15, L.P.?
NEA Partners 15, L.P. has an estimated net worth of $812 Million. This is based on reported shares across multiple companies, which include Desktop Metal, Inc., Cascadian Therapeutics, Inc., Arcellx, Inc., Robinhood Markets, Inc., Nkarta, Inc., Berkshire Grey, Inc., Bright Health Group Inc., AVEO PHARMACEUTICALS, INC., IonQ, Inc., Nightstar Therapeutics plc, Reneo Pharmaceuticals, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., Annexon, Inc., ARCA biopharma, Inc., Senti Biosciences, Inc.\, and Achaogen Inc.
SEC CIK
NEA Partners 15, L.P.'s CIK is 0001640031
Past Insider Trading and Trends
2018 was NEA Partners 15, L.P.'s most active year for acquiring shares with 26 total transactions. NEA Partners 15, L.P.'s most active month to acquire stocks was the month of July. 2021 was NEA Partners 15, L.P.'s most active year for disposing of shares, totalling 24 transactions. NEA Partners 15, L.P.'s most active month to dispose stocks was the month of July. 2021 saw NEA Partners 15, L.P. paying a total of $87,118,710.00 for 208,503,857 shares, this is the most they've acquired in one year. In 2019 NEA Partners 15, L.P. cashed out on 6,662,532 shares for a total of $169,894,566.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nightstar Therapeutics plc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.66M |
$25.50 | -$169,894,566.00 |
0
|
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Berkshire Grey, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -38.18M |
—
|
—
|
0
|
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Reneo Pharmaceuticals, Inc. (RPHM) Snapshot price: $1.64
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.79M |
$15.00 |
—
| 4.79M |
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Arcellx, Inc. (ACLX) Snapshot price: $64.14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -29.65% | -2.00M |
—
|
—
| 4.75M |
Dec 20
| |||
Form 4
| +4.86% | 312.5K |
$16.00 | $5,000,000.00 | 6.75M |
Jun 21
| |||
Form 4
|
∞
| 6.43M |
$15.00 | $23,749,995.00 | 6.43M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
IonQ, Inc. (IONQ) Snapshot price: $10.385
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -44.44% | -11.69M |
—
|
—
| 14.61M |
Nov 16
| |||
Form 4
| -10.00% | -2.92M |
$5.84 | -$17,073,458.62 | 26.31M |
May 26 - May 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |